BABA vs BKE

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

BKE's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises concern about bankruptcy risk, though the company maintains strong profitability metrics including a 41.26% ROE and 16.13% profit margin. Trading at $50.28, the stock is below its intrinsic value of $84.46 and Graham Number of $30.6, suggesting undervaluation on a defensive basis, but the lack of analyst coverage and neutral insider activity limit conviction. The 52-week range ($33.12–$61.69) and recent 6-month decline highlight volatility, while earnings growth remains solid but inconsistent.